What is the cost of Kymriah?
Medically reviewed by Drugs.com. Last updated on Sep 30, 2020.
Official Answer
by Drugs.comAccording to Novartis, the manufacturer of Kymriah (tisagenlecleucel), the cancer therapy will cost $475,000 for one treatment course.
Kymriah is a chimeric antigen receptor T cell (CAR-T) therapy for use in pediatric and young adult patients (up to age 25) with relapsed or refractory (r/r) B-cell acute lymphoblastic leukemia (ALL).
Related Medical Questions
- How is Kymriah administered?
- What type of drug is Kymriah (tisagenlecleucel)?
- What is the lifetime or cumulative dose for Adriamycin?
- Is Sprycel a chemotherapy drug?
- Gleevec vs Sprycel vs Tasigna - how do they compare?
- What to avoid when taking Gleevec?
- How long does it take Sprycel (dasatinib) to start working?
- How much does Blincyto (blinatumomab) cost?
- How does Gleevec (imatinib) work?
- Is there a generic for Gleevec?
- Is Blincyto (blinatumomab) chemotherapy?
- How is Blincyto taken / administered?
- Can I take Gleevec while pregnant?
- How does Asparlas (calaspargase pegol-mknl) compare to Oncaspar (pegaspargase)?
- How does Besponsa work to treat acute lymphoblastic leukemia (ALL)?
Drug Information
Related Support Groups
- Kymriah (3 questions, 3 members)
- Acute Lymphoblastic Leukemia (18 questions, 14 members)